USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: MICRONIX, INC.
Address: MICRONIX, INC.
14950 GREYHOUND CT, STE 307
CARMEL, IN 46032
Located in HUBZone: No
Woman-Owned: Yes
Minority-Owned: No
URL: N/A
Phone: (317) 844-4324

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $790,918.00 11
SBIR Phase II $4,269,403.00 7

Award List:

CHOLESTEROL THRESHOLD ASSAY

Award Year / Program / Phase: 1989 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00

CHOLESTEROL THRESHOLD ASSAY

Award Year / Program / Phase: 1992 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $417,683.00
Abstract:
This project will develop a blood-test strip for cholesterol. plasma is separated on the strip from cells by a patented filtration process through a glass fiber fleece, collecting the plasma on a detachable recipient member and eluting it into a liquid reagent. cholesterol esterase (che) and oxidase… More

Rapid Teststrip Assay for Acetaminophen and Salicylate

Award Year / Program / Phase: 1994 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hans Kloepfer
Award Amount: $80,214.00

Rapid Teststrip Assay for Acetaminophen and Salicylate

Award Year / Program / Phase: 1995 / SBIR / Phase II
Agency: HHS
Principal Investigator: Hans Kloepfer
Award Amount: $749,603.00
Abstract:
Acetaminophen and salicylates are contained in over 200 prescription and non-prescriptionformulations. Of all intentional and unintentional overdose ingestions of pharmaceutical andnon-pharmaceutical compounds, those of acetaminophen and salicylates are the most frequent, both innumber of exposures… More

Method for Isolation and Microassay of Lipoprotein (A)

Award Year / Program / Phase: 1995 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mary Gaunt Kloepfer
Award Amount: $81,000.00

NOVEL ENZYMIC ASSAYS FOR TOTAL AND CONJUGATED BILIRUBIN

Award Year / Program / Phase: 1996 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $80,250.00

Method for Isolation and Microassay of Lipoprotein (A)

Award Year / Program / Phase: 1997 / SBIR / Phase II
Agency: HHS
Principal Investigator: Mary Gaunt Kloepfer
Award Amount: $592,416.00
Abstract:
Lipoprotein(a) [Lp(a)] has been labelled the most atherogenic lipoprotein in man. Current laboratorLp(a) employ immuno-quantitation of its apolipoprotein [apo(a)]. Because these methods are hamperedto plasminogen, apo(a) isoform dependence, antibody heterogeneity, and lack of standardization,… More

N/A

Award Year / Program / Phase: 1999 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $729,645.00

NOVEL ASSAY METHODS FOR ETHYLENE GLYCOL TOXICITY

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hans G. Kloepfer
Award Amount: $99,510.00
Abstract:
Not Available Recent discoveries of plant-like organelles in Plasmodium falciparum, the organism that causes malaria, provide potential new avenues toward treatment and prevention of this deadly disease. More specifically, it is now known that the Shikimate Pathway, an enzymatic pathway that… More

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hans G. Kloepfer
Award Amount: $100,000.00

Novel Assay for Ethylene Glycol Toxicity

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hans G. Kloepfer
Award Amount: $0.00
Abstract:
DESCRIPTION: (Applicant's abstract) Poisoning from ethylene glycol is a potentially lethal medical emergency but can be treated effectively when recognized early. Conversely, when diagnosis is late, the outcome is usually poor. The major pathogenic factor is… More

Novel Assay for Ethylene Glycol Toxicity

Award Year / Program / Phase: 2001 / SBIR / Phase II
Agency: HHS
Principal Investigator: Hans G. Kloepfer
Award Amount: $382,201.00
Abstract:
DESCRIPTION: (Applicant's abstract) Poisoning from ethylene glycol is a potentially lethal medical emergency but can be treated effectively when recognized early. Conversely, when diagnosis is late, the outcome is usually poor. The major pathogenic factor is… More

NOVEL SOLID STATE DIABETES MONITORING SYSTEM

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Charles W. Roach
Award Amount: $100,000.00
Abstract:
DESCRIPTION (Adapted from the Investigator's Abstract): Liver failure is a major cause of death in the U.S. There is a great need for a liver assist device for temporary support of liver failure patients. Algenix is developing a bioartificial liver to meet this critical… More

CONSOLIDATED DIABETES SCREENING DEVICE

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mary A. Gauntkloepfer
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): Of the 120 million diabetics in the world, one half are undiagnosed and therefore deprived of the proven benefits of tight glucose control in curbing diabetes-related complications. Recognizing this problem the American Diabetes Association and National Diabetes… More

Novel Solid State Diabetes Monitoring System

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hans G. Kloepfer
Award Amount: $0.00
Abstract:
DESCRIPTION (provided by applicant): The applicant organization proposes to develop an ultra-miniaturized, minimally invasive diabetes monitoring system for estimating concentrations of diabetes-related parameters (analytes) in whole blood. The system is comprised of analyte specific test tabs… More

Novel Solid State Diabetes Monitoring System

Award Year / Program / Phase: 2003 / SBIR / Phase II
Agency: HHS
Principal Investigator: Hans G. Kloepfer
Award Amount: $652,257.00
Abstract:
DESCRIPTION (provided by applicant): The applicant organization proposes to develop an ultra-miniaturized, minimally invasive diabetes monitoring system for estimating concentrations of diabetes-related parameters (analytes) in whole blood. The system is comprised of analyte specific test tabs… More

Novel Devices for Management of Toxic Alcohol Exposure

Award Year / Program / Phase: 2005 / SBIR / Phase II
Agency: HHS
Principal Investigator: Hans G. Kloepfer
Award Amount: $745,598.00
Abstract:
DESCRIPTION (provided by applicant): The applicant organization proposes to develop ultra-miniaturized, minimally invasive test wand methods for quantification in whole blood specimens of methanol, formate, ethylene glycol, and glycolate, the four critical analytes in the laboratory evaluation of… More

Non-instrumented Device for Diabetic/Vascular Risk S

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mary Gauntkloepfer
Award Amount: $99,944.00
Abstract:
DESCRIPTION (provided by applicant): More than half of the world's diabetics and individuals at risk for atherosclerosis due to high blood glucose and lipids (cholesterol, triglyceride) are undiagnosed. A fast growing component of this huge patient population are people with metabolic syndrome. Most… More